Pain. Generalized pain NOS
Conditions
Interventions
Intervention 1: Intervention group: Patients in Group dexmedetomidine will be received 39 ml of bupivacaine 0.25% with 1 ml (1 µg/kg) dexmedetomidine. Intervention 2: Control group: Patients in Grou
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Aged 20-60 years old American Society of Anesthesiologists physical status classification I General anesthesia
Exclusion criteria
Exclusion criteria: History of cardiovascular disease History of respiratory disease History of renal disease History of liver disease Pregnancy Allergy to the drugs studied Contraindication of supraclavicular block Coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale.;Duration of the sensory block. Timepoint: From the onset of the sensory block until the onset of the first pain after surgery. Method of measurement: Pinprick.;Duration of the motor block. Timepoint: Since full paralysis of limb until complete restoration of limb movement. Method of measurement: Bromage scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Arterial Blood Pressure. Timepoint: During surgery. Method of measurement: None Invasive Blood Pressure.;Mean pulse Rate. Timepoint: During surgery. Method of measurement: Electrocardiogram.;Pentazocine consumption. Timepoint: After transferring the patient to the ward in the first 24 hours. Method of measurement: milligram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahryar Sane
Oroumia University of Medical Sciences
Outcome results
None listed